Babesiosis / Tick Fever

Babesiosis, commonly known as tick fever or redwater fever, is a significant tick-borne parasitic disease affecting cattle and other livestock worldwide. This condition is caused by intraerythrocytic protozoan parasites of the genus Babesia, which invade and destroy red blood cells, leading to severe hemolytic anemia and potentially fatal systemic disease. The disease represents one of the most economically important tick-borne conditions affecting the global cattle industry, with significant impact on animal health, productivity, and international livestock trade. Understanding babesiosis is essential for producers operating in endemic regions and those importing cattle from areas where the disease is prevalent.

Babesiosis primarily affects cattle, though related Babesia species can infect sheep, goats, horses, pigs, and wild ruminants. In cattle, the two most important species are Babesia bovis and Babesia bigemina, each producing distinct clinical syndromes and requiring specific diagnostic approaches. Babesia bovis infections tend to be more severe, often causing cerebral babesiosis due to sequestration of infected red blood cells in brain capillaries. Babesia bigemina produces classic redwater fever with prominent hemoglobinuria and jaundice. The geographic distribution of babesiosis corresponds closely with the range of competent tick vectors, primarily Rhipicephalus (Boophilus) species, making the disease endemic throughout tropical and subtropical regions of Africa, Asia, Australia, Central and South America, and parts of southern Europe and the United States.

The economic and welfare impact of babesiosis on cattle populations is substantial, with losses attributed to mortality, decreased productivity, treatment costs, and trade restrictions. In endemic areas, acute babesiosis can cause mortality rates exceeding fifty percent in susceptible adult cattle, while chronically infected animals suffer reduced weight gain and milk production. The costs of tick control programs, veterinary treatment, and vaccination represent significant ongoing expenses for producers in affected regions. International trade in cattle and genetic material is complicated by babesiosis status, with importing countries requiring testing and treatment protocols that add cost and complexity to transactions.

Early detection and prompt treatment are critical for successful babesiosis management, as the disease can progress rapidly from mild clinical signs to severe anemia and death within days. Animals in endemic areas often develop partial immunity through repeated exposure, creating a state of endemic stability where clinical disease is uncommon despite widespread infection. However, introduction of naive animals into endemic areas or breakdown of endemic stability due to intensive tick control can result in devastating outbreaks. Veterinary involvement in diagnosis, treatment, and prevention planning is essential for managing babesiosis risk at both individual animal and herd levels.

The primary cause of babesiosis is infection with protozoan parasites of the genus Babesia, transmitted through the bite of infected ticks. Babesia bovis and Babesia bigemina are the most important species affecting cattle, while Babesia ovis affects sheep and Babesia caballi and Theileria equi affect horses. These parasites undergo complex life cycles involving both the tick vector and mammalian host. When an infected tick feeds on a susceptible animal, sporozoites are injected with tick saliva and rapidly invade red blood cells, where they multiply asexually through binary fission. The resulting merozoites rupture from infected cells and invade new erythrocytes, perpetuating the infection cycle and causing progressive red blood cell destruction.

Tick vector biology plays a crucial role in babesiosis transmission and epidemiology. Rhipicephalus microplus, formerly known as Boophilus microplus, serves as the primary vector for both Babesia bovis and Babesia bigemina in most endemic regions. This one-host tick completes its entire life cycle on a single animal, with transmission of Babesia occurring transovarially from infected female ticks to their offspring. Rhipicephalus annulatus also transmits both species in some regions. The efficiency of transmission varies with tick species, Babesia species, and environmental conditions affecting tick survival and reproduction. Understanding local tick populations and their seasonal activity patterns is essential for effective disease prevention.

Environmental and management factors significantly influence babesiosis risk in cattle populations. Climate conditions affecting tick populations, including temperature, humidity, and rainfall patterns, determine seasonal disease incidence and geographic distribution. Introduction of cattle from tick-free areas into endemic regions poses high risk, as naive animals lack immunity and often experience severe clinical disease. Intensive tick control programs can paradoxically increase babesiosis risk by disrupting endemic stability, leaving animals susceptible to severe disease if tick control fails. Movement of infected ticks on animals, equipment, or vehicles can introduce babesiosis to previously unaffected areas.

Risk factors for clinical babesiosis include immune status, age at first exposure, and concurrent stressors. Young calves born to immune dams receive passive immunity through colostrum and typically experience mild infections that stimulate active immunity, contributing to endemic stability. Animals first exposed as adults suffer more severe disease than those exposed as calves. Pregnancy, concurrent disease, poor nutrition, and other stressors can increase disease severity in infected animals. Splenectomized animals are extremely susceptible to severe babesiosis, as the spleen plays a critical role in removing infected red blood cells from circulation.

The pathophysiology of babesiosis involves both direct effects of parasite multiplication and host immune responses to infection. Destruction of red blood cells by emerging merozoites causes hemolytic anemia, the hallmark of babesiosis. Hemoglobin released from lysed cells is processed by the liver and excreted by the kidneys, producing the characteristic jaundice and hemoglobinuria of redwater fever. Babesia bovis causes additional pathology through cytoadherence, where infected cells stick to capillary endothelium, leading to microvascular obstruction and tissue hypoxia. Cerebral babesiosis occurs when this sequestration affects brain vessels, causing neurological signs and rapid death. Inflammatory responses to infection contribute to fever, anorexia, and systemic illness.

Early warning signs of babesiosis in cattle often begin subtly before progressing to more obvious clinical disease. Initial symptoms may include mild fever, slight decrease in appetite, and reduced activity that observant producers might notice. Affected animals may separate from the herd and show decreased interest in grazing. Subtle changes in milk production or decreased feed efficiency in feedlot animals may precede obvious illness. Early detection at this stage offers the best opportunity for successful treatment, though the nonspecific nature of initial signs makes early diagnosis challenging without laboratory confirmation.

Common symptoms of babesiosis vary somewhat between the two main causative species, though significant overlap exists. Babesia bigemina infections classically produce redwater fever, characterized by high fever reaching 106-108°F (41-42°C), anemia with pale or jaundiced mucous membranes, and hemoglobinuria causing dark red to brown urine. Babesia bovis infections may produce less dramatic hemoglobinuria but cause more severe systemic illness and neurological complications. Both infections cause progressive weakness, elevated heart and respiratory rates, and decreased appetite. Pregnant animals may abort, and bulls may experience temporary or permanent fertility impairment.

Behavioral changes associated with babesiosis reflect the debilitating effects of severe anemia and systemic inflammation. Affected cattle become progressively lethargic, reluctant to move, and may lag behind the herd when moved. Isolation-seeking behavior is common, with sick animals finding quiet areas away from herdmates. Decreased rumination and reduced feed intake accelerate weight loss and weakness. Animals may show signs of discomfort, including grinding teeth, kicking at the abdomen, or abnormal postures. Depression deepens as disease progresses, with severely affected animals becoming recumbent and unresponsive.

Physical signs of babesiosis progress with disease severity and duration. Anemia causes progressive pallor of mucous membranes, visible in the gums, conjunctiva, and vulva. Jaundice develops as hemoglobin breakdown products accumulate, causing yellow discoloration of mucous membranes and visible sclera. Tachycardia and tachypnea reflect cardiovascular compensation for reduced oxygen-carrying capacity. Fever is typically present early in infection but may subside in advanced cases. Enlarged spleen and liver may be palpable on rectal examination in some cases. Dehydration develops secondary to fever and reduced water intake.

Symptom progression in untreated babesiosis can be rapid, particularly with Babesia bovis infection. Initial mild signs may progress to severe anemia and cardiovascular collapse within three to seven days. Hemoglobinuria typically appears within the first few days of clinical illness and may persist for several days. Without treatment, affected animals become progressively weaker, eventually becoming recumbent. Terminal stages involve cardiovascular shock, multi-organ failure, and death. Babesia bovis infections may show sudden deterioration due to cerebral involvement, with animals progressing from mild illness to death within twenty-four hours.

Emergency symptoms requiring immediate veterinary intervention include severe anemia indicated by white or extremely pale mucous membranes, collapse or inability to rise, neurological signs including incoordination, circling, head pressing, aggression, or convulsions, and signs of cardiovascular shock including rapid weak pulse, cold extremities, and altered consciousness. Dark red or brown urine indicates significant hemoglobinuria requiring urgent treatment. High fever above 107°F (41.7°C) suggests acute severe infection needing immediate intervention. Any recumbent animal with suspected babesiosis should receive emergency veterinary care, as the prognosis worsens dramatically once animals become unable to stand.

Clinical examination for suspected babesiosis involves systematic assessment of cardinal signs and identification of findings consistent with hemolytic disease. Evaluation of mucous membrane color provides immediate information about anemia and jaundice status. Body temperature measurement typically reveals fever in acute cases. Auscultation of heart and lungs may detect tachycardia and increased respiratory sounds associated with anemia-induced compensation. Assessment of hydration status through skin turgor and eye position guides fluid therapy decisions. Examination for tick infestation provides epidemiological context, though ticks may no longer be present when clinical signs appear. Neurological examination is essential when Babesia bovis infection is suspected.

Diagnostic testing for babesiosis employs multiple approaches to confirm infection and assess severity. Examination of Giemsa-stained blood smears under microscopy allows direct visualization of Babesia organisms within red blood cells, providing rapid definitive diagnosis in many cases. Babesia bigemina appears as paired piriform bodies, while Babesia bovis organisms are smaller and often appear as single rings. Parasitemia levels may be low, particularly in Babesia bovis infections where sequestration removes infected cells from circulation, necessitating careful examination of multiple fields. Packed cell volume measurement quantifies anemia severity and guides treatment intensity. Serological tests, including indirect fluorescent antibody tests and enzyme-linked immunosorbent assays, detect antibodies to Babesia species, useful for identifying carrier animals and herd screening but less helpful for acute diagnosis. Polymerase chain reaction testing provides sensitive and specific detection of Babesia DNA, valuable for confirming infection when parasitemia is low.

Differential diagnosis for babesiosis includes other conditions causing hemolytic anemia, fever, and jaundice in cattle. Anaplasmosis, caused by the rickettsial organism Anaplasma marginale, produces similar clinical signs but without hemoglobinuria, as red blood cell destruction is primarily extravascular. Theileriosis, caused by various Theileria species, occurs in overlapping geographic regions and can produce hemolytic disease. Leptospirosis causes hemolytic disease in some cases and should be considered. Bacillary hemoglobinuria (redwater disease) caused by Clostridium haemolyticum produces dramatic hemoglobinuria but is not tick-associated. Copper toxicity in sheep causes acute hemolysis with hemoglobinuria. Autoimmune hemolytic anemia and other non-infectious causes of anemia require consideration when tick exposure is uncertain.

Herd-level diagnostics for babesiosis support strategic disease management and prevention planning. Serological surveys determine herd exposure status and identify the proportion of immune versus susceptible animals, information critical for managing endemic stability. Tick surveys characterize vector populations and seasonal activity patterns. Testing of introduced animals before or during quarantine identifies potential infection sources. Following outbreaks, systematic testing helps define the scope of infection and identify animals requiring treatment. Geographic information systems and epidemiological modeling can predict babesiosis risk based on tick distribution, climate factors, and cattle movement patterns.

Emergency treatment for severe babesiosis requires immediate intervention to prevent death from overwhelming parasitemia and severe anemia. Diminazene aceturate (Berenil) and imidocarb dipropionate (Imizol) are the primary antiprotozoal drugs effective against Babesia species. Diminazene aceturate at 3.5 mg/kg body weight intramuscularly provides rapid parasiticidal action and is often preferred for acute cases. Blood transfusion may be necessary for severely anemic animals, with whole blood from a compatible donor improving oxygen-carrying capacity while antiprotozoal drugs eliminate the infection. Intravenous fluid therapy supports cardiovascular function and maintains renal perfusion to facilitate hemoglobin clearance. Anti-inflammatory drugs may reduce fever and improve comfort but should be used judiciously considering withdrawal times.

Medical management of babesiosis centers on antiprotozoal therapy with appropriate supportive care. Imidocarb dipropionate at 1.2-3.0 mg/kg subcutaneously or intramuscularly is effective against both Babesia bovis and Babesia bigemina, with higher doses providing longer protection against reinfection. Treatment may be repeated after seven to fourteen days if parasitemia persists. Withdrawal times for meat and milk must be strictly observed, with imidocarb requiring particularly long withdrawal periods in some formulations. Iron supplementation supports red blood cell regeneration during recovery. Vitamin B complex injections may benefit anemic animals. Oral or intravenous fluids maintain hydration in animals with reduced water intake.

There are no surgical options specifically indicated for babesiosis treatment. However, emergency supportive procedures may be necessary for complications. Rumen trocarization may be required if bloat develops secondary to recumbency and decreased motility. Surgical intervention might be needed for calving difficulties in affected pregnant cows. Necropsy examination of fatal cases provides diagnostic confirmation and valuable information for herd health management.

Supportive care for babesiosis patients addresses the metabolic demands of fighting infection and recovering from anemia. Shade and shelter protect anemic animals from heat stress, which can be fatal when oxygen-carrying capacity is compromised. High-quality nutrition with palatable feeds encourages intake in recovering animals. Easy access to clean water is essential, as dehydration compounds the effects of anemia. Quiet rest without forced movement allows recovering animals to conserve energy. Nursing care for recumbent animals, including repositioning and padded bedding, prevents secondary complications.

Herd treatment protocols may be implemented during outbreaks or when managing endemic stability. Mass treatment of all cattle in an affected group ensures elimination of clinical and subclinical infections. Strategic treatment timed with seasonal tick activity can reduce disease incidence during high-risk periods. Pretreatment of animals before introduction to endemic areas may be combined with tick treatment and controlled exposure to build immunity safely. Coordination of treatment with tick control maximizes effectiveness by reducing reinfection pressure during the vulnerable post-treatment period.

Treatment decisions for babesiosis must consider individual animal value, prognosis, and economic factors. Animals with severe anemia or neurological signs have guarded to poor prognosis even with treatment, and owners should be counseled about expected outcomes. Treatment costs, including medications, veterinary services, and lost production during recovery, may exceed the value of commercial animals. High-value breeding animals or animals with sentimental value may warrant more intensive and expensive treatment approaches. In some cases, humane euthanasia may be the most appropriate option for severely affected animals with poor prognosis. Veterinarians should provide clear prognostic information to enable informed decision-making.

Recovery timelines for babesiosis vary considerably based on disease severity at treatment initiation, the specific Babesia species involved, and individual animal factors. Animals treated early in infection, before severe anemia develops, may show clinical improvement within twenty-four to forty-eight hours and return to normal activity within a week. Severely anemic animals require longer recovery periods, typically two to four weeks, for red blood cell regeneration to restore normal oxygen-carrying capacity. Animals that experienced cerebral babesiosis may have persistent neurological deficits affecting long-term function. Complete hematological recovery, with packed cell volume returning to normal ranges, may take four to eight weeks depending on the degree of anemia experienced.

Post-treatment care and monitoring ensure complete recovery and detect potential complications or relapses. Treated animals should be observed daily for return of clinical signs indicating treatment failure or reinfection. Periodic assessment of mucous membrane color provides simple monitoring of anemia status. Follow-up blood smears or PCR testing may be warranted to confirm parasite clearance, particularly in valuable animals or those that experienced severe disease. Recovered animals typically develop immunity to clinical disease but may remain carriers, capable of infecting ticks and serving as infection sources for susceptible animals. Monitoring for concurrent infections, including anaplasmosis which often occurs alongside babesiosis, ensures comprehensive health management.

Prognosis factors for babesiosis include the degree of anemia at treatment, presence of neurological signs, concurrent conditions, and promptness of treatment. Animals maintaining packed cell volume above fifteen percent generally have good prognosis with appropriate treatment. Severe anemia with packed cell volume below ten percent carries guarded prognosis even with intensive treatment. Neurological signs indicating cerebral babesiosis dramatically worsen prognosis, with many affected animals dying despite treatment. Concurrent anaplasmosis or other diseases complicates recovery and worsens outcomes. Prompt treatment before severe anemia develops offers the best chance for complete recovery.

Return to production considerations for recovered babesiosis patients include withdrawal time compliance, fertility assessment, and appropriate workload resumption. Meat and milk withdrawal times for antiprotozoal drugs must be strictly observed to ensure food safety. Imidocarb may require withdrawal periods of several weeks depending on formulation and dose. Reproductive function should be evaluated in breeding animals, as severe babesiosis can cause temporary or permanent fertility impairment in both males and females. Pregnant animals that survived acute babesiosis should be monitored for abortion or compromised calf health. Gradual return to normal activity, rather than immediate full production demands, supports sustained recovery and reduces relapse risk.

Vaccination protocols for babesiosis prevention are available in some endemic regions and provide valuable protection for susceptible cattle. Live attenuated vaccines against Babesia bovis and Babesia bigemina have been used successfully in Australia, South Africa, and some South American countries. Vaccination typically involves inoculation of young cattle between three and twelve months of age with attenuated parasites, producing mild infection that stimulates protective immunity. Vaccine reactions can occur, and animals should be monitored following vaccination. Killed vaccines have shown limited efficacy and are less commonly used. Vaccination programs should be coordinated with veterinary guidance and adapted to local disease epidemiology.

Biosecurity measures for babesiosis prevention focus primarily on tick control and management of animal movements. Introduction of cattle from tick-free regions into endemic areas poses significant risk, and such animals should receive prophylactic treatment, vaccination if available, and careful monitoring. Quarantine of introduced animals allows observation for disease development and treatment before herd integration. Movement of cattle from endemic to tick-free areas requires treatment to eliminate carrier infections and prevent disease introduction. Equipment and vehicles moving between areas should be cleaned to prevent tick transport. Maintaining awareness of babesiosis status in neighboring herds and regions supports informed biosecurity decisions.

Tick control represents the primary means of babesiosis prevention in many situations and can be achieved through various methods. Acaricide application through dipping, spraying, or pour-on formulations kills ticks and prevents transmission. Strategic tick control timed to seasonal activity patterns maximizes effectiveness while minimizing selection for resistance. Pasture management, including rotational grazing that breaks tick life cycles, reduces environmental tick populations. Biological control using tick-parasitic wasps or fungal pathogens is under development. Selection and breeding of tick-resistant cattle, particularly breeds with Bos indicus genetics, provides sustainable long-term tick management. Integrated tick management combining multiple approaches achieves optimal control while reducing reliance on any single method.

Management practices that maintain endemic stability provide practical protection in regions where babesiosis cannot be eliminated. Endemic stability exists when most cattle in a population develop immunity through natural exposure at a young age, when maternal antibodies provide protection. Avoiding intensive tick control that might disrupt endemic stability requires careful consideration of overall disease management goals. Ensuring young calves receive adequate colostrum from immune dams supports passive immunity transfer. Gradual controlled exposure of introduced cattle to local tick populations, combined with careful monitoring and prompt treatment if needed, can establish immunity while minimizing clinical disease risk.

Quarantine and testing protocols protect herds and regions from babesiosis introduction. Animals imported from endemic regions should be tested for Babesia infection and treated if positive before release from quarantine. Serological testing identifies animals with prior exposure, while PCR testing detects current infections. Quarantine periods allow observation for clinical disease development that might not be detected by testing alone. Documentation of testing results and health certificates provides assurance for buyers and receiving regions. Coordination with regulatory veterinary authorities ensures compliance with applicable requirements for disease prevention.

Daily management and monitoring of cattle in babesiosis-endemic areas requires consistent attention to animal health and early disease recognition. Regular observation of cattle, ideally twice daily, allows early detection of subtle signs including separation from the herd, decreased grazing, and mild depression. Assessment of mucous membrane color during routine handling provides quick screening for anemia. Temperature monitoring during high-risk periods or when early signs are noted enables early diagnosis. Recording of clinical observations creates valuable documentation for tracking disease patterns and evaluating control program effectiveness. Training of farm staff in babesiosis recognition improves surveillance across the operation.

Housing and environmental management strategies can reduce babesiosis risk through tick habitat modification and animal protection. Vegetation management that reduces tick habitat near cattle areas decreases exposure risk. Provision of shade and shelter is particularly important for animals recovering from babesiosis, as heat stress compounds the effects of anemia. Handling facilities should allow safe restraint for examination and treatment of affected animals. Separate accommodation for sick animals enables intensive monitoring and treatment while preventing transmission to susceptible herdmates through tick vectors. Clean water sources maintained free from contamination support overall herd health.

Herd health programs in babesiosis-endemic areas should incorporate disease surveillance, prevention measures, and treatment protocols into comprehensive management plans. Regular veterinary consultation ensures programs remain current with best practices and adapted to local conditions. Vaccination schedules, where applicable, should be incorporated into routine health management. Tick control programs require planning and consistent implementation throughout transmission seasons. Monitoring of treatment outcomes and disease incidence provides feedback for program refinement. Integration of babesiosis management with other herd health priorities ensures efficient resource use.

Record keeping and monitoring systems support effective babesiosis management at individual and herd levels. Individual animal records should document disease history, treatments administered with dates and withdrawal periods, and outcomes. Vaccination records ensure appropriate timing of boosters and identification of unvaccinated animals. Tick treatment records track acaricide use and support resistance management. Production records may reveal subclinical disease effects on weight gain or milk production. Disease incidence tracking over time identifies trends and evaluates control program effectiveness. Electronic systems facilitate data analysis and reporting.

Economic considerations significantly influence babesiosis management decisions in cattle operations. Prevention costs, including tick control products, vaccines, and labor for implementation, represent ongoing operational expenses. Treatment costs for clinical cases include veterinary fees, medications, and lost production during recovery. Death losses from severe cases directly impact profitability. Trade implications, including testing requirements and market access restrictions, affect operations involved in cattle sales beyond local markets. Economic analysis comparing different management strategies helps identify optimal approaches for specific situations. Insurance products covering livestock losses may offset some disease-related costs in some regions.

High-risk breeds for babesiosis include Bos taurus cattle of European origin, which lack the innate resistance found in tropically adapted breeds. Holstein, Hereford, Angus, and other British and Continental breeds experience more severe disease when infected with Babesia species. These breeds developed in temperate regions without significant tick pressure and did not undergo selection for tick resistance or babesiosis tolerance. Introduction of susceptible European breeds into endemic tropical and subtropical regions for genetic improvement has historically caused significant losses from babesiosis and other tick-borne diseases. Crossbreeding with resistant breeds can improve babesiosis tolerance while maintaining production characteristics.

Production type considerations affect babesiosis risk and management in cattle populations. High-producing dairy cattle, often of Holstein breeding, are particularly susceptible to severe babesiosis and face additional challenges from production stress. Beef cattle in extensive grazing systems experience ongoing tick exposure that may maintain endemic stability but also continuous disease pressure. Feedlot cattle, often concentrated in regions where babesiosis is less prevalent, may be highly susceptible if exposed. Breeding cattle require protection of fertility, which can be compromised by babesiosis infection. Show cattle and those undergoing frequent transportation face variable tick exposure that may disrupt immunity patterns.

Genetic selection and breed considerations offer long-term strategies for managing babesiosis in endemic regions. Bos indicus breeds, including Brahman, Nelore, and Gir cattle, demonstrate significant resistance to ticks and tick-borne diseases including babesiosis. This resistance involves both reduced tick burden and immune responses that limit parasite multiplication. Crossbreeding programs incorporating Bos indicus genetics into Bos taurus populations can produce composite breeds with improved tick resistance while maintaining acceptable production levels. Some studies have identified specific genetic markers associated with tick resistance and babesiosis tolerance that may enable more targeted selection. Breed selection should consider the balance between disease resistance and production goals appropriate for specific management systems and market requirements.

Commonly co-occurring conditions with babesiosis include other tick-borne diseases that share similar vectors and geographic distributions. Anaplasmosis, caused by Anaplasma marginale, is frequently diagnosed alongside babesiosis and may cause combined infection that is more severe than either disease alone. Theileriosis, caused by various Theileria species, occurs in some regions where babesiosis is endemic. Tick worry and anemia from heavy tick infestation compounds the effects of babesiosis infection. Secondary bacterial infections may develop in debilitated animals, requiring additional treatment. Nutritional deficiencies may be unmasked or worsened by the metabolic demands of fighting infection and regenerating blood cells.

Conditions with similar symptoms to babesiosis require careful differentiation during diagnostic workup. Anaplasmosis produces fever, anemia, and jaundice similar to babesiosis but typically without hemoglobinuria, as red blood cell destruction is primarily extravascular. Bacillary hemoglobinuria causes dramatic hemoglobinuria and can resemble redwater fever but is caused by Clostridium haemolyticum and is not tick-associated. Leptospirosis may cause hemolytic disease in some cases. Postparturient hemoglobinuria occurs in phosphorus-deficient cattle and must be differentiated from infectious causes. Copper toxicity in cattle causes acute hemolysis similar to babesiosis. Plant toxicities affecting red blood cells, including those from brassicas and onions, should be considered when appropriate exposure history exists.

Complications and sequelae of babesiosis can significantly affect long-term animal health and productivity. Severe anemia may cause hypoxic damage to vital organs, including heart and kidneys, with lasting functional impairment. Cerebral babesiosis survivors may have persistent neurological deficits affecting coordination, behavior, or vision. Reproductive complications include abortion in pregnant animals and temporary or permanent fertility impairment in both sexes. Carrier states persist in recovered animals, creating potential infection sources for tick vectors and susceptible herdmates. Immunosuppression during acute disease may allow opportunistic infections to develop. Chronic debilitation from severe or repeated infections can permanently affect growth and production potential.